Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

422 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Anti-gp41 antibody levels reflect HIV viral suppression and cellular reservoir in long-term antiretroviral-treated trial participants.
Delagreverie HM, Grude M, Lambert-Niclot S, Nere ML, Jadand C, Leport C, Raffi F, Ghislain M, Goujard C, Meyer L, Calvez V, Katlama C, Flandre P, Barin F, Delaugerre C. Delagreverie HM, et al. Among authors: leport c. J Antimicrob Chemother. 2019 May 1;74(5):1389-1394. doi: 10.1093/jac/dkz004. J Antimicrob Chemother. 2019. PMID: 30690509 Clinical Trial.
Factors associated with non-adherence to long-term highly active antiretroviral therapy: a 10 year follow-up analysis with correction for the bias induced by missing data.
Protopopescu C, Raffi F, Roux P, Reynes J, Dellamonica P, Spire B, Leport C, Carrieri MP; ANRS CO8 APROCO-COPILOTE Study Group. Protopopescu C, et al. Among authors: leport c. J Antimicrob Chemother. 2009 Sep;64(3):599-606. doi: 10.1093/jac/dkp232. Epub 2009 Jul 14. J Antimicrob Chemother. 2009. PMID: 19602563
Is clinical practice concordant with the changes in guidelines for antiretroviral therapy initiation during primary and chronic HIV-1 infection? The ANRS PRIMO and COPANA cohorts.
Krastinova E, Seng R, Yeni P, Viard JP, Vittecoq D, Lascoux-Combe C, Fourn E, Pahlavan G, Delfraissy JF, Goujard C, Meyer L; ANRS PRIMO and COPANA Cohorts. Krastinova E, et al. PLoS One. 2013 Aug 1;8(8):e71473. doi: 10.1371/journal.pone.0071473. Print 2013. PLoS One. 2013. PMID: 23936509 Free PMC article.
Increased systemic immune activation and inflammatory profile of long-term HIV-infected ART-controlled patients is related to personal factors, but not to markers of HIV infection severity.
Bastard JP, Fellahi S, Couffignal C, Raffi F, Gras G, Hardel L, Sobel A, Leport C, Fardet L, Capeau J; ANRS CO8 APROCO-COPILOTE Cohort Study Group. Bastard JP, et al. Among authors: leport c. J Antimicrob Chemother. 2015;70(6):1816-24. doi: 10.1093/jac/dkv036. Epub 2015 Mar 1. J Antimicrob Chemother. 2015. PMID: 25733587
Failure to achieve immunological recovery in HIV-infected patients with clinical and virological success after 10 years of combined ART: role of treatment course.
Raffi F, Le Moing V, Assuied A, Habak S, Spire B, Cazanave C, Billaud E, Dellamonica P, Ferry T, Fagard C, Leport C; ANRS CO8 COPILOTE Study Group. Raffi F, et al. Among authors: leport c. J Antimicrob Chemother. 2017 Jan;72(1):240-245. doi: 10.1093/jac/dkw369. Epub 2016 Sep 13. J Antimicrob Chemother. 2017. PMID: 27629069
Brief Report: Prolonged Viral Suppression Over a 12-Year Follow-up of HIV-Infected Patients: The Persistent Impact of Adherence at 4 Months After Initiation of Combined Antiretroviral Therapy in the ANRS CO8 APROCO-COPILOTE Cohort.
Protopopescu C, Carrieri MP, Raffi F, Picard O, Hardel L, Piroth L, Jadand C, Pierret J, Spire B, Leport C; ANRS CO8 APROCO-COPILOTE Study Group. Protopopescu C, et al. Among authors: leport c. J Acquir Immune Defic Syndr. 2017 Mar 1;74(3):293-297. doi: 10.1097/QAI.0000000000001249. J Acquir Immune Defic Syndr. 2017. PMID: 27861235
High variability of indinavir and nelfinavir pharmacokinetics in HIV-infected patients with a sustained virological response on highly active antiretroviral therapy.
Goujard C, Legrand M, Panhard X, Diquet B, Duval X, Peytavin G, Vincent I, Katlama C, Leport C, Bonnet B, Salmon-Céron D, Mentré F, Taburet AM; COPHAR1-ANRS 102 Study Group. Goujard C, et al. Among authors: leport c. Clin Pharmacokinet. 2005;44(12):1267-78. doi: 10.2165/00003088-200544120-00005. Clin Pharmacokinet. 2005. PMID: 16372824 Clinical Trial.
422 results